MiMedx (NASDAQ: MDXG) GC gains PSU shares, withholds some for taxes

Rhea-AI Filing Summary

MIMEDX GROUP General Counsel and CAO William Frank Hulse IV received common shares through the vesting of performance stock units at $4.50 per share. A portion of the vested shares was withheld to cover tax obligations, leaving him with 563,440 directly owned shares after these transactions.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Hulse William Frank IV

Role General Counsel and CAO

Type	Security	Shares	Price	Value
Exercise	Common Stock	136,364	$4.50	$614K
Tax Withholding	Common Stock	61,460	$4.50	$277K

Holdings After Transaction: Common Stock — 624,900 shares (Direct)

Footnotes (1)

1. Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13. 2023. The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hulse William Frank IV

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT NE

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and CAO

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		136,364(1)	A	$4.5	624,900	D
Common Stock	03/10/2026		F		61,460(2)	D	$4.5	563,440	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13. 2023.

2. The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.

Remarks:

	/s/William F. Hulse	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MIMEDX (MDXG) executive William Frank Hulse IV report in this Form 4?

He reported vesting of performance stock units into common stock and related tax withholding. Shares were issued at $4.50 per share, and some were withheld to satisfy tax liabilities required by company policy.

How many MIMEDX (MDXG) shares did Hulse acquire through vesting on this date?

He acquired 136,364 shares of common stock through the vesting of performance stock units. These shares relate to a performance period from January 1, 2023 to December 31, 2025, granted on March 13, 2023.

How many MIMEDX (MDXG) shares were withheld for taxes in this Form 4?

The filing shows 61,460 common shares were disposed of as a tax‑withholding transaction at $4.50 per share. This withholding was required by company policy upon vesting of the performance stock units.

What is Hulse’s MIMEDX (MDXG) share ownership after these transactions?

After the vesting and tax‑withholding transactions, Hulse directly holds 563,440 shares of MIMEDX common stock. This figure reflects his updated direct ownership position following the performance stock unit payout and related tax share withholding.

Were the MIMEDX (MDXG) transactions an open-market buy or sell?

No, the transactions were not open‑market trades. They reflect automatic vesting of performance stock units and required share withholding to pay tax liabilities, rather than discretionary purchases or sales on the market.